GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acrux Ltd (ASX:ACR) » Definitions » Current Accrued Expense

Acrux (ASX:ACR) Current Accrued Expense : A$0.00 Mil (As of Dec. 2023)


View and export this data going back to 2004. Start your Free Trial

What is Acrux Current Accrued Expense?

Acrux's Current Accrued Expense for the quarter that ended in Dec. 2023 was A$0.00 Mil.

Acrux Current Accrued Expense Historical Data

The historical data trend for Acrux's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acrux Current Accrued Expense Chart

Acrux Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Current Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Acrux Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Acrux Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Acrux Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Acrux's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Acrux (ASX:ACR) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acrux Ltd (ASX:ACR) » Definitions » Current Accrued Expense
Comparable Companies
ASX:NYR ASX:1AI ASX:1AD ASX:PAB ASX:NOX ASX:BGT ASX:VBS ASX:BTC ASX:RAD ASX:TRP OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB XBRU:ARGX BNTX
Traded in Other Exchanges
ARUXF:USA FJY:Germany
Address
103-113 Stanley Street, West Melbourne, Melbourne, VIC, AUS, 3003
Website
https://www.acrux.com.au
Acrux Ltd is a pharmaceutical company dedicated to developing and commercializing generic transdermal and topical prescription pharmaceuticals. The group is formulating and developing a range of topical generic products by leveraging its skilled workforce, on-site laboratories, GMP manufacturing suite, and technical, clinical, and commercial experience to bring affordable products to market. Geographically, it has a presence in Australia; the United States; Europe, and other countries. The firm operates in a single segment and derives revenue from developing and commercializing pharmaceutical products that administer drugs topically. Its product pipeline products include Lenzetto, Evamist, Testosterone Topical Solution, and among others.